Table 1.
Cervical dilatation | Station of fetal head | Initial dose | Subsequent dose | ||
---|---|---|---|---|---|
Centimeters | Level | Medication, and intrathecal dose | Intrathecal volume (ml) | Medication, and epidural dose | Epidural volume (ml) |
2–3 | − 2/− 1 | Sufentanil 2.5 mg | 5 | Ropivacaine 0.05–0.10% or levobupivacaine 0.05–0.0625% | 15–20 |
3–5 | − 1 | Ropivacaine 0.04% or levobupivacaine 0.025% and sufentanil 2.5 mg | 5 | Ropivacaine 0.05–0.10% or levobupivacaine 0.0625% | 15–20 |
> 6 | − 1 | Ropivacaine 0.05–0.06% or levobupivacaine 0.03–0.04% and sufentanil 2.5 mg | 5 | Ropivacaine 0.10% or levobupivacaine 0.0625% | 20 |
Full cervical dilatation | − 1/0 | Ropivacaine 0.06% or levobupivacaine 0.05% | 5 | Ropivacaine 0.15% or levobupivacaine 0.0625% | 15 |
At full cervical dilation, after the complete rotation of the fetal head, it can be administered 5–7 ml of mepivacaine or lidocaine 1% for perineal analgesia or for an episiotomy/episiorrhaphy